Pathogenic role for macrophage migration inhibitory factor in glioblastoma and its targeting with specific inhibitors as novel tailored therapeutic approach
Katia Mangano(University of Catania), Ferdinando Nicoletti(University of Catania), Santa Mammana(University of Catania), Maria Sofia Basile(University of Catania), Maria Cristina Petralia(University of Messina), Emanuela Mazzon(Centro Neurolesi Bonino Pulejo), Placido Bramanti(Centro Neurolesi Bonino Pulejo), Roberto Di Marco(University of Catania), Paolo Fagone(University of Catania)
Cited by 80
Related Papers
Natural products in drug discovery: advances and opportunities
|Nature Reviews Drug Discovery|2021|5.2k
Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR Inhibitors: Rationale and Importance to Inhibiting These Pathways in Human Health
|Oncotarget|2011|579
GSK-3 as potential target for therapeutic intervention in cancer
|Oncotarget|2014|508
The neuropathic pain: An overview of the current treatment and future therapeutic approaches
|International Journal of Immunopathology and Pharmacology|2019|495